Vincent Landré MD , Hans-Christoph Pape MD , Ksenija Slankamenac MD, PhD , Nicole Ochsenbein-Kölble MD , Nina Kimmich MD
{"title":"子宫动脉假性动脉瘤的治疗:非介入治疗1例并系统回顾","authors":"Vincent Landré MD , Hans-Christoph Pape MD , Ksenija Slankamenac MD, PhD , Nicole Ochsenbein-Kölble MD , Nina Kimmich MD","doi":"10.1016/j.xagr.2025.100555","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Uterine artery pseudoaneurysm (UAP) is a rare but potentially life-threatening condition that can result in severe hemorrhage. Due to its nonspecific clinical presentation, it is often misdiagnosed, leading to delays in appropriate intervention. UAP commonly arises following uterine trauma, including cesarean section, vaginal delivery, and other gynecological procedures or pathologies, such as endometriosis. While selective arterial embolization is the preferred treatment, noninterventional management may be a viable alternative in selected cases.</div></div><div><h3>Case Report</h3><div>We present a case of a 33-year-old woman in her first pregnancy diagnosed with UAP at 27 gestational weeks (GW). She complained about intermittent left lower abdominal pain without vaginal bleeding. Initial imaging with Doppler ultrasonography and noncontrast magnetic resonance imaging (MRI) identified a left paracervical mass consistent with a UAP. Further imaging with contrast-enhanced MRI confirmed the diagnosis and revealed thrombosis of the lesion. Given the absence of perfusion and clinical stability, a noninterventional approach was pursued. The patient remained hemodynamically stable and was discharged after 6 days of hospitalization. At 38+4 GW, she underwent a scheduled cesarean section, and both maternal and neonatal outcomes were favorable. Follow-up at 12 months postdiagnosis showed no recurrence or complications.</div></div><div><h3>Methods</h3><div>A systematic review was conducted, analyzing peer-reviewed studies from 1955 to 2024 in PubMed and EMBASE databases. Inclusion criteria focused on human studies reporting UAP, with data extracted on risk factors, diagnostic modalities, treatment strategies, and clinical outcomes. Statistical analyses included the Student’s <em>t</em> test for continuous variables and the Pearson chi-square test for categorical variables.</div></div><div><h3>Results</h3><div>Out of 790 initially identified articles, 131 met inclusion criteria, comprising 144 patients with uterine artery UAP. Among these, 20 patients were pregnant, and 124 were nonpregnant. Comorbidities were more common in pregnant patients (55% vs 34.7%). Prior uterine manipulation occurred in 50% of pregnant and 90.3% of nonpregnant cases, with laparotomy and cesarean sections being most frequent. Vaginal bleeding was the most common symptom in nonpregnant patients (81.5%), while pain dominated in pregnant cases (85%). Imaging primarily involved ultrasound and angiography, combined with computed tomography (CT) in nonpregnant women (70% vs 35%) and MRI in pregnancy (70% vs 11.3%). Embolization was the main treatment (90% in pregnancy, 99% in nonpregnant), with few complications and no reported deaths. Statistical analysis showed a significant association in nonpregnant patients between vaginal bleeding and the need for transfusion (<em>P</em><.05), as well as between bleeding and smaller UAP size (24.5 vs 32.3 mm, <em>P</em><.05).</div></div><div><h3>Conclusion</h3><div>UAP is rare and potentially serious. Vaginal bleeding is the most common presentation in nonpregnant patients, while pain is more frequent in pregnancy. Smaller UAPs were more likely to bleed in nonpregnant patients, suggesting rupture risk isn’t solely size-dependent. Diagnostics can be performed by ultrasound, angiography, and CT, or in pregnancy, especially by MRI. Embolization is highly effective and remains the standard of care. Noninterventional management may be cautiously considered in hemodynamically stable patients with spontaneously thrombosed or nonperfused UAPs, though evidence of its effectiveness remains limited. An individualized, multidisciplinary management remains the key. Further data collection will help refine treatment strategies.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100555"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of uterine artery pseudoaneurysm: a case report of noninterventional treatment with systematic review\",\"authors\":\"Vincent Landré MD , Hans-Christoph Pape MD , Ksenija Slankamenac MD, PhD , Nicole Ochsenbein-Kölble MD , Nina Kimmich MD\",\"doi\":\"10.1016/j.xagr.2025.100555\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Uterine artery pseudoaneurysm (UAP) is a rare but potentially life-threatening condition that can result in severe hemorrhage. Due to its nonspecific clinical presentation, it is often misdiagnosed, leading to delays in appropriate intervention. UAP commonly arises following uterine trauma, including cesarean section, vaginal delivery, and other gynecological procedures or pathologies, such as endometriosis. While selective arterial embolization is the preferred treatment, noninterventional management may be a viable alternative in selected cases.</div></div><div><h3>Case Report</h3><div>We present a case of a 33-year-old woman in her first pregnancy diagnosed with UAP at 27 gestational weeks (GW). She complained about intermittent left lower abdominal pain without vaginal bleeding. Initial imaging with Doppler ultrasonography and noncontrast magnetic resonance imaging (MRI) identified a left paracervical mass consistent with a UAP. Further imaging with contrast-enhanced MRI confirmed the diagnosis and revealed thrombosis of the lesion. Given the absence of perfusion and clinical stability, a noninterventional approach was pursued. The patient remained hemodynamically stable and was discharged after 6 days of hospitalization. At 38+4 GW, she underwent a scheduled cesarean section, and both maternal and neonatal outcomes were favorable. Follow-up at 12 months postdiagnosis showed no recurrence or complications.</div></div><div><h3>Methods</h3><div>A systematic review was conducted, analyzing peer-reviewed studies from 1955 to 2024 in PubMed and EMBASE databases. Inclusion criteria focused on human studies reporting UAP, with data extracted on risk factors, diagnostic modalities, treatment strategies, and clinical outcomes. Statistical analyses included the Student’s <em>t</em> test for continuous variables and the Pearson chi-square test for categorical variables.</div></div><div><h3>Results</h3><div>Out of 790 initially identified articles, 131 met inclusion criteria, comprising 144 patients with uterine artery UAP. Among these, 20 patients were pregnant, and 124 were nonpregnant. Comorbidities were more common in pregnant patients (55% vs 34.7%). Prior uterine manipulation occurred in 50% of pregnant and 90.3% of nonpregnant cases, with laparotomy and cesarean sections being most frequent. Vaginal bleeding was the most common symptom in nonpregnant patients (81.5%), while pain dominated in pregnant cases (85%). Imaging primarily involved ultrasound and angiography, combined with computed tomography (CT) in nonpregnant women (70% vs 35%) and MRI in pregnancy (70% vs 11.3%). Embolization was the main treatment (90% in pregnancy, 99% in nonpregnant), with few complications and no reported deaths. Statistical analysis showed a significant association in nonpregnant patients between vaginal bleeding and the need for transfusion (<em>P</em><.05), as well as between bleeding and smaller UAP size (24.5 vs 32.3 mm, <em>P</em><.05).</div></div><div><h3>Conclusion</h3><div>UAP is rare and potentially serious. Vaginal bleeding is the most common presentation in nonpregnant patients, while pain is more frequent in pregnancy. Smaller UAPs were more likely to bleed in nonpregnant patients, suggesting rupture risk isn’t solely size-dependent. Diagnostics can be performed by ultrasound, angiography, and CT, or in pregnancy, especially by MRI. Embolization is highly effective and remains the standard of care. Noninterventional management may be cautiously considered in hemodynamically stable patients with spontaneously thrombosed or nonperfused UAPs, though evidence of its effectiveness remains limited. An individualized, multidisciplinary management remains the key. Further data collection will help refine treatment strategies.</div></div>\",\"PeriodicalId\":72141,\"journal\":{\"name\":\"AJOG global reports\",\"volume\":\"5 3\",\"pages\":\"Article 100555\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AJOG global reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666577825001169\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJOG global reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666577825001169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
动脉假性动脉瘤(UAP)是一种罕见但可能危及生命的疾病,可导致严重出血。由于其非特异性临床表现,它经常被误诊,导致适当干预的延误。UAP通常发生在子宫外伤后,包括剖宫产、阴道分娩和其他妇科手术或病理,如子宫内膜异位症。虽然选择性动脉栓塞是首选的治疗方法,但在某些情况下,非介入治疗可能是一种可行的选择。病例报告:我们报告一例33岁女性首次妊娠,27孕周时诊断为UAP。她主诉间歇性左下腹疼痛,无阴道出血。最初的多普勒超声和非对比磁共振成像(MRI)发现了一个符合UAP的左侧宫颈旁肿块。进一步的MRI造影证实了诊断,并发现病变处有血栓形成。考虑到缺乏灌注和临床稳定性,采用非介入性方法。患者血流动力学保持稳定,住院6天后出院。在38+4 GW时,她接受了预定的剖宫产,产妇和新生儿的结局都是有利的。随访12个月,无复发及并发症。方法对1955 ~ 2024年PubMed和EMBASE数据库中同行评议的研究进行系统回顾分析。纳入标准侧重于报告UAP的人类研究,并提取有关风险因素、诊断方式、治疗策略和临床结果的数据。统计分析包括对连续变量的学生t检验和对分类变量的皮尔逊卡方检验。结果在最初确定的790篇文章中,131篇符合纳入标准,包括144例子宫动脉UAP患者。其中怀孕20例,未怀孕124例。合并症在孕妇中更为常见(55% vs 34.7%)。50%的孕妇和90.3%的非孕妇有过子宫操作史,其中剖腹手术和剖宫产手术最为常见。阴道出血是非妊娠患者最常见的症状(81.5%),而疼痛以妊娠患者为主(85%)。成像主要包括超声和血管造影,在非孕妇中结合计算机断层扫描(CT)(70%对35%)和在孕妇中结合MRI(70%对11.3%)。栓塞是主要的治疗方法(90%为妊娠,99%为非妊娠),并发症很少,无死亡报告。统计分析显示,在非妊娠患者中,阴道出血与输血需要之间存在显著关联(P< 0.05),出血与较小的UAP尺寸之间存在显著关联(24.5 vs 32.3 mm, P< 0.05)。结论uap是一种罕见且有潜在危害性的疾病。阴道出血是非妊娠患者最常见的表现,而疼痛在妊娠患者中更为常见。较小的uap在未怀孕的患者中更容易出血,这表明破裂风险并不完全取决于尺寸。诊断可以通过超声、血管造影和CT进行,或者在怀孕时,特别是通过MRI进行。栓塞术非常有效,仍然是标准的治疗方法。对于血流动力学稳定的自发性血栓形成或未灌注的uap患者,尽管其有效性的证据仍然有限,但应谨慎考虑非介入治疗。个性化的、多学科的管理仍然是关键。进一步的数据收集将有助于完善治疗策略。
Management of uterine artery pseudoaneurysm: a case report of noninterventional treatment with systematic review
Background
Uterine artery pseudoaneurysm (UAP) is a rare but potentially life-threatening condition that can result in severe hemorrhage. Due to its nonspecific clinical presentation, it is often misdiagnosed, leading to delays in appropriate intervention. UAP commonly arises following uterine trauma, including cesarean section, vaginal delivery, and other gynecological procedures or pathologies, such as endometriosis. While selective arterial embolization is the preferred treatment, noninterventional management may be a viable alternative in selected cases.
Case Report
We present a case of a 33-year-old woman in her first pregnancy diagnosed with UAP at 27 gestational weeks (GW). She complained about intermittent left lower abdominal pain without vaginal bleeding. Initial imaging with Doppler ultrasonography and noncontrast magnetic resonance imaging (MRI) identified a left paracervical mass consistent with a UAP. Further imaging with contrast-enhanced MRI confirmed the diagnosis and revealed thrombosis of the lesion. Given the absence of perfusion and clinical stability, a noninterventional approach was pursued. The patient remained hemodynamically stable and was discharged after 6 days of hospitalization. At 38+4 GW, she underwent a scheduled cesarean section, and both maternal and neonatal outcomes were favorable. Follow-up at 12 months postdiagnosis showed no recurrence or complications.
Methods
A systematic review was conducted, analyzing peer-reviewed studies from 1955 to 2024 in PubMed and EMBASE databases. Inclusion criteria focused on human studies reporting UAP, with data extracted on risk factors, diagnostic modalities, treatment strategies, and clinical outcomes. Statistical analyses included the Student’s t test for continuous variables and the Pearson chi-square test for categorical variables.
Results
Out of 790 initially identified articles, 131 met inclusion criteria, comprising 144 patients with uterine artery UAP. Among these, 20 patients were pregnant, and 124 were nonpregnant. Comorbidities were more common in pregnant patients (55% vs 34.7%). Prior uterine manipulation occurred in 50% of pregnant and 90.3% of nonpregnant cases, with laparotomy and cesarean sections being most frequent. Vaginal bleeding was the most common symptom in nonpregnant patients (81.5%), while pain dominated in pregnant cases (85%). Imaging primarily involved ultrasound and angiography, combined with computed tomography (CT) in nonpregnant women (70% vs 35%) and MRI in pregnancy (70% vs 11.3%). Embolization was the main treatment (90% in pregnancy, 99% in nonpregnant), with few complications and no reported deaths. Statistical analysis showed a significant association in nonpregnant patients between vaginal bleeding and the need for transfusion (P<.05), as well as between bleeding and smaller UAP size (24.5 vs 32.3 mm, P<.05).
Conclusion
UAP is rare and potentially serious. Vaginal bleeding is the most common presentation in nonpregnant patients, while pain is more frequent in pregnancy. Smaller UAPs were more likely to bleed in nonpregnant patients, suggesting rupture risk isn’t solely size-dependent. Diagnostics can be performed by ultrasound, angiography, and CT, or in pregnancy, especially by MRI. Embolization is highly effective and remains the standard of care. Noninterventional management may be cautiously considered in hemodynamically stable patients with spontaneously thrombosed or nonperfused UAPs, though evidence of its effectiveness remains limited. An individualized, multidisciplinary management remains the key. Further data collection will help refine treatment strategies.
AJOG global reportsEndocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Perinatology, Pediatrics and Child Health, Urology